新型及未充分利用疫苗的引进：维持可及性、疾病控制及基础设施发展。
Introduction of new and underutilized vaccines: sustaining access, disease control, and infrastructure development.
作者信息
Andrus Jon Kim, Fitzsimmons John
机构信息
Family and Community Health, Pan American Health Organization, Washington, DC, United States of America.
出版信息
PLoS Med. 2005 Oct;2(10):e286. doi: 10.1371/journal.pmed.0020286. Epub 2005 Sep 13.
Abstract
For vaccines to reach the greatest number of people requires access, accelerated regional disease control, and the development of public health infrastructure.
摘要
要让疫苗惠及尽可能多的人，需要具备可及性、加快区域疾病防控以及发展公共卫生基础设施。
相似文献
1
Introduction of new and underutilized vaccines: sustaining access, disease control, and infrastructure development.
PLoS Med. 2005 Oct;2(10):e286. doi: 10.1371/journal.pmed.0020286. Epub 2005 Sep 13.
2
[Analysis of the model of health services delivery].
Educ Med Salud. 1992 Jul-Sep;26(3):298-425.
3
Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.
AIDS. 2003 Oct 17;17(15):W1-10. doi: 10.1097/01.aids.0000076356.20434.a0.
4
Advances in palliative care in Latin America and the Caribbean: ongoing projects of the Pan American Health Organization (PAHO).
J Palliat Med. 2001 Summer;4(2):228-31.
5
The introduction of new vaccines into developing countries. IV: Global Access Strategies.
Vaccine. 2007 May 16;25(20):4003-11. doi: 10.1016/j.vaccine.2007.02.047. Epub 2007 Mar 7.
6
A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.
Reprod Health Matters. 2008 Nov;16(32):59-66. doi: 10.1016/S0968-8080(08)32405-7.
7
[Inversion in vaccines].
Medicina (B Aires). 2004;64(2):178-80.
8
Therapeutic vaccines: a solution to the prevention problem?
Vaccine. 2005 Mar 18;23(17-18):2363-6. doi: 10.1016/j.vaccine.2005.01.026.
9
Global health experts explore ways to slash vaccine prices and expand access.
BMJ. 2011 May 25;342:d3287. doi: 10.1136/bmj.d3287.
10
The need for new vaccines.
Vaccine. 2009 Dec 30;27 Suppl 6:G3-8. doi: 10.1016/j.vaccine.2009.10.014.
引用本文的文献
1
Cost-effectiveness of birth-dose hepatitis B vaccination among refugee populations in the African region: a series of case studies.
Confl Health. 2019 Feb 26;13:5. doi: 10.1186/s13031-019-0188-y. eCollection 2019.
本文引用的文献
1
Progress in vaccination against hepatitis B in the Americas.
J Clin Virol. 2005 Dec;34 Suppl 2:S14-9. doi: 10.1016/s1386-6532(05)80029-0.
2
Anticipating new vaccines in the Americas.
Rev Panam Salud Publica. 2004 Dec;16(6):369-70. doi: 10.1590/s1020-49892004001200001.
3
Rubella elimination and improving health care for women.
Emerg Infect Dis. 2004 Nov;10(11):2017-21. doi: 10.3201/eid1011.040428.
4
Elimination of rubella and congenital rubella syndrome in the Americas: another opportunity to address inequities in health.
Rev Panam Salud Publica. 2004 Mar;15(3):145-6. doi: 10.1590/s1020-49892004000300001.
Zotero 插件